So far, there is no direct evidence of high extracellular IL-33 on cancer cell migration except for the studies in rat cardiac fibroblasts that revealed significant migration suppression by 1-100 ng/ml IL-33 37 and in human trophoblast choriocarcinoma cells for invasion attenuation 38. This evidence concerns the gene IL33 and cancer.